More information
Description
Cancer is a major public health problem in Romania. Malignant tumors account for two out of 10 deaths recorded in Romania, ranking second place among the main causes of death after cardiovascular diseases. Among EU member states, Romania has the highest incidence of cervical cancer (13.1/100,000 Romania compared to an average of 3.29/100,000 in EU). One of the causes of this unusually large incidence of cervical cancer in Romania is the deficiency of the medical system in early detecting the HPV persistent infection and cervical precancerous lesions which, treated, prevents cancer.
The project proposed to improve the quality of integrated preventive and curative medical services related to cervical cancer prevention among the disadvantaged population at risk living in communities from remote areas. The main project results are: 7,000 preventive cancer screening tests for vulnerable women, 1.000 vaccinations against Human papillomavirus (HPV), 1500 women treated with a mobile unit or in ambulatory care, 30000 women informed on cervical cancer prevention by the door to door campaign, 1 post-doctoral study and policy recommendations related on cervical cancer screening and quality assurance.
The project is implemented by Oncology Institute Cluj-Napoca in partnership with Norwegian Cancer Registry. The partnership will support the exchange of experience for the implementation of effective screening programs and also the achievement of the technical quality conditions of screening programs to be performed in Romania. Also, the Norwegian partner will conduct a study using participatory action research (PAR) aiming to bring out knowledge about how the Romanian health care system can make robust solutions that facilitate women''s participation, and ensure adequate follow-up and treatment of women when needed. Guidelines for screening testing and follow-up must also be addressed and amended.